Phytotherapy Research 2013-01-01

Potential antidepressant activity of Areca catechu nut via elevation of serotonin and noradrenaline in the hippocampus of rats.

Ghulam Abbas, Sabira Naqvi, Shaista Erum, Shakil Ahmed, Atta-ur-Rahman, Ahsana Dar

Index: Phytother Res. 27(1) , 39-45, (2013)

Full Text: HTML

Abstract

The current study was aimed at investigating the potential antidepressant activity of Areca catechu nut ethanol extract and its various fractions using behavioral (acute and sub-chronic forced swim tests) and biochemical (monoamines and their metabolite levels using high performance liquid chromatography) tests. The areca nut ethanol extract and its aqueous fraction exhibited antidepressant activity in both acute and sub-chronic forced swim tests (IC₅₀ ~ 50 and 20 mg/kg, respectively), which was further confirmed by unaltered locomotor (horizontal and vertical) activities of rats in the activity cage. Phytochemical analysis revealed that saponins of areca nut may be the active component in its antidepressant action. The rats treated sub-chronically with areca nut extract displayed toxic effects, whereas its active aqueous fraction was non-toxic, indicating the presence of different constituents for antidepressant and toxic effects. In the hippocampus of rats, the areca nut extract (50 mg/kg) and aqueous fraction (20 mg/kg) caused a significant elevation of serotonin (around 35%) and noradrenaline (around 30%) compared with the control (261 ± 25 and 512 ± 29 ng/g, respectively). In conclusion, the areca nut possesses potential antidepressant effect via the elevation of serotonin and noradrenaline.Copyright © 2012 John Wiley & Sons, Ltd.


Related Compounds

  • Phenelzine (sulfat...

Related Articles:

Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs.

[Biol. Psychiatry 34(6) , 1467-81, (2009)]

Monoamine oxidase inhibitors revisited: what you should know.

2013-02-01

[J. Clin. Psychiatry 74(2) , 189-91, (2013)]

Potential repurposing of known drugs as potent bacterial β-glucuronidase inhibitors.

2012-08-01

[J. Biomol. Screen. 17(7) , 957-65, (2012)]

The antidepressant phenelzine enhances memory in the double Y-maze and increases GABA levels in the hippocampus and frontal cortex of rats

2012-07-01

[Pharmacol. Biochem. Behav. 102(1) , 109-17, (2012)]

Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments.

2008-05-23

[Brain Res. 1211 , 37-43, (2008)]

More Articles...